Elevance Health, Inc. financial data

Symbol
ELV on NYSE
Location
Indianapolis, IN
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 06 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 149% % 2.7%
Debt-to-equity 179% % 3.5%
Return On Equity 13% % -8.7%
Return On Assets 4.7% % -11%
Operating Margin 3.6% % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 220,704,667 shares -2.9%
Common Stock, Shares, Outstanding 220,723,898 shares -3%
Entity Public Float $87,349,478,366 USD -25%
Common Stock, Value, Issued $2,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 224,000,000 shares -3.3%
Weighted Average Number of Shares Outstanding, Diluted 224,600,000 shares -3.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $199,125,000,000 USD 12%
Operating Income (Loss) $7,199,000,000 USD -8.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,710,000,000 USD -15%
Income Tax Expense (Benefit) $1,049,000,000 USD -46%
Net Income (Loss) Attributable to Parent $5,662,000,000 USD -5.3%
Earnings Per Share, Basic 25.28 USD/shares -2.1%
Earnings Per Share, Diluted 25.21 USD/shares -1.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $9,491,000,000 USD 15%
Other Assets, Current $5,344,000,000 USD 14%
Assets, Current $63,001,000,000 USD 6.9%
Other Long-term Investments $10,839,000,000 USD 11%
Property, Plant and Equipment, Net $4,679,000,000 USD 0.58%
Operating Lease, Right-of-Use Asset $452,000,000 USD -20%
Intangible Assets, Net (Excluding Goodwill) $11,200,000,000 USD -7.4%
Goodwill $28,344,000,000 USD 0.24%
Other Assets, Noncurrent $2,310,000,000 USD 7.9%
Assets $121,494,000,000 USD 3.9%
Liabilities, Current $41,035,000,000 USD 1.1%
Deferred Income Tax Liabilities, Net $2,110,000,000 USD -1.8%
Operating Lease, Liability, Noncurrent $529,000,000 USD -20%
Other Liabilities, Noncurrent $3,381,000,000 USD 1.7%
Liabilities $77,468,000,000 USD 2.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $451,000,000 USD 61%
Retained Earnings (Accumulated Deficit) $35,393,000,000 USD 5.5%
Stockholders' Equity Attributable to Parent $43,882,000,000 USD 6.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $44,026,000,000 USD 6.3%
Liabilities and Equity $121,494,000,000 USD 3.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,017,000,000 USD -49%
Net Cash Provided by (Used in) Financing Activities $1,909,000,000 USD -6066%
Net Cash Provided by (Used in) Investing Activities $103,000,000 USD
Common Stock, Shares Authorized 900,000,000 shares 0%
Common Stock, Shares, Issued 220,723,898 shares -3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $788,000,000 USD -163%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9,491,000,000 USD 15%
Deferred Tax Assets, Valuation Allowance $311,000,000 USD 5.8%
Deferred Tax Assets, Gross $2,431,000,000 USD 0.83%
Operating Lease, Liability $660,000,000 USD -19%
Payments to Acquire Property, Plant, and Equipment $196,000,000 USD -30%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $6,358,000,000 USD 3.4%
Lessee, Operating Lease, Liability, to be Paid $743,000,000 USD -16%
Property, Plant and Equipment, Gross $8,735,000,000 USD 4.9%
Operating Lease, Liability, Current $131,000,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $133,000,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One $159,000,000 USD -14%
Operating Lease, Weighted Average Discount Rate, Percent 0.0405 pure 2.3%
Deferred Income Tax Expense (Benefit) $174,000,000 USD -228%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $83,000,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $121,000,000 USD -4.7%
Deferred Tax Assets, Operating Loss Carryforwards $617,000,000 USD 44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $547,000,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Four $110,000,000 USD -1.8%
Additional Paid in Capital $8,938,000,000 USD 0.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $628,000,000 USD 8.3%
Depreciation, Depletion and Amortization $231,000,000 USD 5%
Deferred Tax Assets, Net of Valuation Allowance $2,120,000,000 USD 0.14%
Interest Expense $1,104,000,000 USD 10%